Screener
Sionna Therapeutics SION Business Segments — External research and development expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept sionna:ExternalResearchAndDevelopmentExpense.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development expenses: | ||
| External research and development expenses(1) | $12,931 | $9,978 |
| Personnel-related expenses, excluding stock-based compensation | 3,479 | 2,383 |
| Facility and information technology allocated expenses | 485 | 440 |
| General and administrative expenses: | ||
| Personnel-related expenses, excluding stock-based compensation | 3,865 | 2,232 |
| General corporate and facility expenses(2) | 1,986 | 1,943 |
| Other segment items(3) | 4,033 | (494) |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's business segments — external research and development expense?
- Sionna Therapeutics (SION) reported business segments — external research and development expense of $12.93M in Q1 2026.
- How has Sionna Therapeutics's business segments — external research and development expense changed year-over-year?
- Sionna Therapeutics's business segments — external research and development expense increased by 29.6% year-over-year, from $9.98M to $12.93M.
- What does business segments — external research and development expense mean?
- Represents the direct costs incurred by a business segment for outsourced research and development activities, including contract research organizations and external laboratory services. This metric tracks the financial commitment to external innovation and clinical development pipelines essential for product advancement. Monitoring this helps investors assess the intensity of external investment in the company's core therapeutic research.
Ask your AI about Sionna Therapeutics's business segments — external research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude